Di Buzzy mmj labs

Circa la società

MMJ Labs was established in 2006 by pediatric emergency physician and pain researcher Amy Baxter. Inspired by the need to control needle pain, Dr. Baxter set out to develop reusable, physiologic products for home and hospital. Initial R&D funded by the NIH launched the flagship product Buzzy®, a palm sized device combining cold and vibration. When placed "between the brain and the pain", the competing stimuli can eliminate or inhibit pain. Since the official product launch in 2009, Buzzy® has been used for over 31 million needle procedures. Buzzy is in over 5,000 hospitals and clinics, with 100,000 units sold. With multiple patents and FDA 510 clearances for controlling pain from IVs, blood draws and cosmetic injections, muscle injury and myofascial trigger point pain, the company has broadened the product line to include VibraCool Sport Therapy and DistrACTION®products. New low back pain device will launch in 2018.